Anni Winckelmann

Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial

Thomas A. Rasmussen, Martin Tolstrup, Christel R. Brinkmann et al. · The Lancet HIV · 2014 · 641 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Effects of 24-week Toll-like receptor 9 agonist treatment in HIV type 1+ individuals

Line K. Vibholm, Christina Valbirk Konrad, Mariane Høgsbjerg Schleimann et al. · AIDS · 2019 · 94 citations

Life Sciences, Immunology, Pharmacology +17

Broad activation of latent HIV-1 in vivo

Kirston Barton, Bonnie Hiener, Anni Winckelmann et al. · Nature Communications · 2016 · 70 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +16

In vitro Characterization of Fitness and Convalescent Antibody Neutralization of SARS-CoV-2 Cluster 5 Variant Emerging in Mink at Danish Farms

Ria Lassaunière, Jannik Fonager, Morten Rasmussen et al. · Frontiers in Microbiology · 2021 · 53 citations · Full text

Life Sciences, Infectious Diseases, Veterinary Microbiology +17

Administration of a Toll-Like Receptor 9 Agonist Decreases the Proviral Reservoir in Virologically Suppressed HIV-Infected Patients

Anni Winckelmann, Lærke V. Munk-Petersen, Thomas A. Rasmussen et al. · PLoS ONE · 2013 · 52 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17